ASCEND BY NTHRYS
Research Abroad Products

Personalized Medicine Project Topics

Browse all focused areas across all project categories under this field.

Showing 25–36 of 200 project topics
Cancer Treatment Response Prediction Using Tumor Genomics AI
A specialized diagnostic AI tool that analyzes tumor genetic mutations and molecular profiles to predict chemotherapy, immunotherapy, and targeted therapy responses before treatment initiation. Monetizes through diagnostic test fees, licensing to oncology clinics and hospital systems, and partnership agreements with oncology pharmaceutical manufacturers.
Personalized Medicine AI Analytics Platform Click to view more details →
Mental Health Medication Personalization through Neurogenomic Testing
A telemedicine-integrated platform that uses genetic and neurobiological markers to recommend optimized psychiatric medications and dosing for depression, anxiety, and other mental health conditions. Captures revenue through testing fees, direct-to-consumer SaaS subscriptions, and B2B contracts with behavioral health clinics and telehealth providers.
Personalized Medicine AI Analytics Platform Click to view more details →
Rare Disease Patient Matching and Treatment Protocol Recommendation
An AI-powered registry and analytics platform that matches rare disease patients with appropriate clinical trials, specialized centers, and personalized treatment protocols based on genetic and phenotypic data. Generates revenue from rare disease biotech companies, academic medical centers, patient advocacy organizations, and orphan drug manufacturers seeking patient identification and enrollment.
Personalized Medicine AI Analytics Platform Click to view more details →
Cardiovascular Risk Polygenic Score Calculation and Prevention Platform
A commercial health analytics tool that calculates individualized cardiovascular disease risk using polygenic risk scores combined with clinical and lifestyle data to enable precision prevention strategies. Monetizes through partnerships with cardiology clinics, health insurance plans, wellness programs, and direct-to-consumer health subscription services seeking preventive care differentiation.
Personalized Medicine AI Analytics Platform Click to view more details →
Medication Adherence Prediction and Personalized Engagement Tool
A digital therapeutics platform that uses AI to predict medication non-adherence risk and deliver personalized interventions, patient education, and behavioral nudges based on individual genetic, socioeconomic, and psychological factors. Generates B2B SaaS revenue from pharmaceutical companies, health plans, and pharmacies seeking to improve medication adherence rates and treatment outcomes.
Personalized Medicine AI Analytics Platform Click to view more details →
Multi-omics Integration Platform for Personalized Treatment Selection
An enterprise AI analytics solution that unifies genomics, proteomics, metabolomics, and clinical imaging data to create comprehensive molecular profiles for treatment recommendation across disease areas. Creates revenue through licensing to academic medical centers, tertiary care hospitals, and precision medicine research organizations pursuing advanced therapeutic personalization capabilities.
Personalized Medicine AI Analytics Platform Click to view more details →
Real-time Genomic Sequencing SaaS for Treatment Selection
A cloud-based platform that processes patient genomic data and matches it against therapeutic databases to recommend personalized treatment protocols within 48 hours. This enables clinics to offer premium precision medicine services while generating recurring subscription revenue from hospital systems and oncology centers.
Biomarker-Guided Therapy Platform Dev Click to view more details →
Multi-Omics Biomarker Integration Engine for Drug Response Prediction
A proprietary software tool that combines genomic, proteomic, and metabolomic data to predict patient drug response with 85%+ accuracy before treatment initiation. Pharma companies license this platform to accelerate clinical trials and reduce development costs by 30-40%.
Biomarker-Guided Therapy Platform Dev Click to view more details →
Liquid Biopsy Companion Diagnostic Platform for Cancer Therapy
A commercialized diagnostic service using cfDNA and circulating tumor cell analysis to identify therapy-resistant mutations before clinical progression. Oncology practices pay per-test fees ($2,000-5,000) while pharmaceutical partners subsidize tests to de-risk their targeted drug portfolios.
Biomarker-Guided Therapy Platform Dev Click to view more details →
AI-Powered Biomarker Discovery Platform for Rare Disease Populations
An enterprise ML platform that mines electronic health records and genomic databases to identify novel biomarkers predictive of treatment outcomes in orphan diseases. Biotech firms and CROs license the discovery platform, reducing biomarker identification timelines from 3 years to 6 months.
Biomarker-Guided Therapy Platform Dev Click to view more details →
Pharmacogenomics Testing and Clinical Decision Support SaaS
An integrated diagnostic and software service that genotypes patients for drug-metabolizing enzyme variants and delivers evidence-based dosing recommendations directly to EHR systems. Health systems generate incremental revenue through improved medication safety outcomes while reducing adverse event costs by 15-25%.
Biomarker-Guided Therapy Platform Dev Click to view more details →
Tumor Microenvironment Profiling Service for Immunotherapy Selection
A specialized diagnostic service that analyzes immune cell infiltration, checkpoint expression, and stromal composition to predict immunotherapy responder status. Cancer centers charge $3,500-6,000 per analysis while partnering with checkpoint inhibitor manufacturers seeking biomarker-enriched patient populations.
Biomarker-Guided Therapy Platform Dev Click to view more details →